Company intelligence / Profile preview

Big Rock Partners Acquisition

Delray Beach, Florida, United States

Ownership: Private
Development stage: Other

Overview

Big Rock Partners Acquisition was a Nasdaq-listed special purpose acquisition company formed to complete a business combination rather than operate a therapeutic pipeline itself. It was founded in 2017 and was based in Delray Beach, Florida. The company targeted acquisitions in healthcare-related areas, but Big Rock itself was not an operating biotech or pharma developer. In December 2020 it announced a merger with NeuroRx, and the transaction closed in May 2021, after which the combined public company began trading as NRx Pharmaceuticals under the ticker NRXP. As a result, Big Rock Partners Acquisition no longer exists as an active standalone operating company.

Industry: Investors

Partnerships

NeuroRx

Beyond the preview

Go deeper on Big Rock Partners Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Big Rock Partners Acquisition.

Explore the full profile